RxDoctor Payments Data

Jessica Palicki

Physician Assistant · Toledo, OHNPI 1841759537

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 90.7% of the total across 939 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 59 manufacturers, the largest accounting for just 16.4% — the pattern of someone who eats at a lot of different presentations. Among physician assistant clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$18,863in general payments, 2019–2025

Across 939 payments — averaging $20.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • EMD Serono, Inc.$3K
  • Biogen$2K
  • MDD US Operations, LLC$2K
  • AbbVie$2K
  • Novartis$1K
  • Teva Pharmaceuticals USA, Inc.$801
  • plus $8K from 53 others

What the payments were for

  • Consulting fees$1,1606%
  • Speaking & faculty fees$860%
  • Food & beverage$17,10291%
  • Education$5143%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
EMD Serono, Inc.53$3,085
Biogen96$2,061
MDD US Operations, LLC101$2,029
AbbVie(2 entities)120$1,819
Novartis64$1,027
Teva Pharmaceuticals USA, Inc.55$801
UCB, Inc.50$724
Johnson & Johnson27$502
AstraZeneca(2 entities)19$473
Lilly USA, LLC23$410
Pfizer20$360
Sanofi13$358
Acadia Pharmaceuticals Inc35$346
Lundbeck LLC22$322
Genentech USA, Inc.17$313
SK Life Science, Inc.13$298
Amneal Pharmaceuticals LLC13$258
Neurelis, Inc.12$253
CSL Behring12$244
Argenx US, Inc.11$219
Amgen(2 entities)10$203
Acorda Therapeutics, Inc11$192
Kyowa Kirin, Inc.4$187
Takeda Pharmaceuticals U.S.A., Inc.8$171
Biohaven Pharmaceuticals, Inc.10$156
Eisai Inc.7$148
Adamas Pharmaceuticals, Inc.16$133
Biohaven Pharmaceutical Holding Company Ltd.9$132
Alnylam Pharmaceuticals Inc.7$124
Jazz Pharmaceuticals Inc.5$120
Avanir Pharmaceuticals, Inc.6$102
Otsuka America Pharmaceutical, Inc.5$99
Upsher-smith Laboratories LLC3$91
Sumitomo Pharma America, Inc.6$87
Vanda Pharmaceuticals Inc.4$87
Sunovion Pharmaceuticals Inc.5$84
TG Therapeutics, Inc.4$66
Catalyst Pharmaceuticals, Inc.3$63
Axsome Therapeutics, Inc.3$57
Azurity Pharmaceuticals, Inc.3$49
Merz Pharmaceuticals, LLC3$48
Supernus Pharmaceuticals, Inc.2$48
Impel Pharmaceuticals Inc.2$46
Mallinckrodt Hospital Products Inc.2$45
Amylyx Pharmaceuticals, Inc.2$44
Cala Health, Inc.3$43
Arbor Pharmaceuticals, Inc.3$38
Mylan Specialty L.p.2$38
Neurocrine Biosciences, Inc.2$37
Banner Life Sciences, LLC2$35
Bristol Myers Squibb2$32
Almatica Pharma LLC2$27
Greenwich Biosciences, Inc.1$23
Nevro Corp.1$21
ANI Pharmaceuticals, Inc.1$20
Medtronic1$18
Livanova USA, Inc.1$18
GRT US Holding, Inc.1$16
Aucta Pharmaceuticals, Inc.1$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$18,863 in reported general payments places this provider in the 95th percentile of 4,098 physician assistant providers in Ohio.

See all physician assistant providers in Ohio

Medicare billing

Part B allowed, 2024
$33,393
Medicare patients
165
Services billed
353

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Nurtec OdtRimegepant Sulfate80$81,621
Aimovig AutoinjectorErenumab-Aooe44$31,917
QuliptaAtogepant27$31,812
UbrelvyUbrogepant27$28,622
NourianzIstradefylline12$25,219
RytaryCarbidopa/Levodopa20$23,295
Ajovy AutoinjectorFremanezumab-Vfrm25$19,346
Dimethyl Fumarate11$19,231
Emgality PenGalcanezumab-Gnlm15$12,277
NamzaricMemantine Hcl/Donepezil Hcl14$10,889
LamictalLamotrigine14$8,305
Lacosamide29$7,284
Levetiracetam95$3,107
Carbidopa-LevodopaCarbidopa/Levodopa119$2,942
Gabapentin175$2,074

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerNurtec Odt$360$81,62180 claims
AbbVieQulipta, Ubrelvy, Namzaric$1,819$71,32468 claims
Kyowa Kirin, Inc.Nourianz$187$25,21912 claims
Amneal Pharmaceuticals LLCRytary$258$23,29520 claims
Upsher-smith Laboratories LLCTopiramate$91$1,234121 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,098 physician assistant providers in Ohio.

Other physician assistant in Toledo

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →